Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rune Sandbu

Showing results (41-50 of 49) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 49 results.
Clinical Pharmacokinetics|March 29, 2023
Neither Gastric Bypass Surgery Nor Diet-Induced Weight-Loss Affect OATP1B1 Activity as Measured by Rosuvastatin Oral ClearanceMarkus Hovd, Ida Robertsen, Line Kristin Johnson, et al.
BMJ Open|May 31, 2018
Impact of body weight, low energy diet and gastric bypass on drug bioavailability, cardiovascular risk factors and metabolic biomarkers: protocol for an open, non-randomised, three-armed single centre study (COCKTAIL)Jøran Hjelmesæth, Anders Åsberg, Shalini Andersson, et al.
The Lancet. Diabetes & Endocrinology|April 4, 2025
Effect of gastric bypass versus sleeve gastrectomy on the remission of type 2 diabetes, weight loss, and cardiovascular risk factors at 5 years (Oseberg): secondary outcomes of a single-centre, triple-blind, randomised controlled trialJostein Wågen Hauge, Heidi Borgeraas, Kåre Inge Birkeland, et al.
JAMA Surgery|July 3, 2024
Gastric Bypass vs Diet and Cardiovascular Risk Factors: A Nonrandomized Controlled TrialCecilia Karlsson, Line Kristin Johnson, Peter J Greasley, et al.
Clinical and Translational Science|August 26, 2021
Short- and long-term effects of body weight loss following calorie restriction and gastric bypass on CYP3A-activity - a non-randomized three-armed controlled trialKine Eide Kvitne, Ida Robertsen, Eva Skovlund, et al.
British Journal of Clinical Pharmacology|April 11, 2022
Short- and long-term effects of body weight, calorie restriction and gastric bypass on CYP1A2, CYP2C19 and CYP2C9 activityKine Eide Kvitne, Veronica Krogstad, Christine Wegler, et al.
Mucosal Immunology|April 13, 2025
A multi-omics microbiome signature is associated with the benefits of gastric bypass surgery and is differentiated from diet induced weight loss through 2 years of follow-upVancheswaran Gopalakrishnan, Chanchal Kumar, Ida Robertsen, et al.
European Journal of Clinical Pharmacology|June 1, 2022
Correlations between 4β-hydroxycholesterol and hepatic and intestinal CYP3A4: protein expression, microsomal ex vivo activity, and in vivo activity in patients with a wide body weight rangeKine Eide Kvitne, Kristine Hole, Veronica Krogstad, et al.
BMJ Open|June 7, 2019
Single-centre, triple-blinded, randomised, 1-year, parallel-group, superiority study to compare the effects of Roux-en-Y gastric bypass and sleeve gastrectomy on remission of type 2 diabetes and β-cell function in subjects with morbid obesity: a protocol for the Obesity <i>s</i>urg<i>e</i>ry in Tøns<i>berg</i> (<i>O</i>seberg) studyHeidi Borgeraas, Jøran Hjelmesæth, Kåre Inge Birkeland, et al.
Pageof 5

Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Clinical Pharmacokinetics|March 29, 2023
Neither Gastric Bypass Surgery Nor Diet-Induced Weight-Loss Affect OATP1B1 Activity as Measured by Rosuvastatin Oral ClearanceMarkus Hovd, Ida Robertsen, Line Kristin Johnson, et al.
BMJ Open|May 31, 2018
Impact of body weight, low energy diet and gastric bypass on drug bioavailability, cardiovascular risk factors and metabolic biomarkers: protocol for an open, non-randomised, three-armed single centre study (COCKTAIL)Jøran Hjelmesæth, Anders Åsberg, Shalini Andersson, et al.
The Lancet. Diabetes & Endocrinology|April 4, 2025
Effect of gastric bypass versus sleeve gastrectomy on the remission of type 2 diabetes, weight loss, and cardiovascular risk factors at 5 years (Oseberg): secondary outcomes of a single-centre, triple-blind, randomised controlled trialJostein Wågen Hauge, Heidi Borgeraas, Kåre Inge Birkeland, et al.
JAMA Surgery|July 3, 2024
Gastric Bypass vs Diet and Cardiovascular Risk Factors: A Nonrandomized Controlled TrialCecilia Karlsson, Line Kristin Johnson, Peter J Greasley, et al.
Clinical and Translational Science|August 26, 2021
Short- and long-term effects of body weight loss following calorie restriction and gastric bypass on CYP3A-activity - a non-randomized three-armed controlled trialKine Eide Kvitne, Ida Robertsen, Eva Skovlund, et al.
British Journal of Clinical Pharmacology|April 11, 2022
Short- and long-term effects of body weight, calorie restriction and gastric bypass on CYP1A2, CYP2C19 and CYP2C9 activityKine Eide Kvitne, Veronica Krogstad, Christine Wegler, et al.
Mucosal Immunology|April 13, 2025
A multi-omics microbiome signature is associated with the benefits of gastric bypass surgery and is differentiated from diet induced weight loss through 2 years of follow-upVancheswaran Gopalakrishnan, Chanchal Kumar, Ida Robertsen, et al.
European Journal of Clinical Pharmacology|June 1, 2022
Correlations between 4β-hydroxycholesterol and hepatic and intestinal CYP3A4: protein expression, microsomal ex vivo activity, and in vivo activity in patients with a wide body weight rangeKine Eide Kvitne, Kristine Hole, Veronica Krogstad, et al.
BMJ Open|June 7, 2019
Single-centre, triple-blinded, randomised, 1-year, parallel-group, superiority study to compare the effects of Roux-en-Y gastric bypass and sleeve gastrectomy on remission of type 2 diabetes and β-cell function in subjects with morbid obesity: a protocol for the Obesity <i>s</i>urg<i>e</i>ry in Tøns<i>berg</i> (<i>O</i>seberg) studyHeidi Borgeraas, Jøran Hjelmesæth, Kåre Inge Birkeland, et al.
Pageof 5